A. officinalis constituents modulate multiple cancer-related pathways, including ERK1/2, PI3K/AKT/mTOR, and apoptosis signaling, reflecting the effects observed in other medicinal plants such as Zingiber officinale and Astragalus membranaceus (Table 1). The gene discussed is MAPK3; the disease is cancer.